Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Artículo en Chino | WPRIM | ID: wpr-971044

RESUMEN

Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease that affects brain function in neonates. At present, mild hypothermia and hyperbaric oxygen therapy are the main methods for the treatment of neonatal HIE; however, they are independent of each other and cannot be combined for synchronous treatment, without monitoring of brain function-related physiological information. In addition, parameter setting of hyperbaric oxygen chamber and mild hypothermia mattress relies on the experience of the medical practitioner, and the parameters remain unchanged throughout the medical process. This article proposes a new device for the treatment of neonatal HIE, which has the modules of hyperbaric oxygen chamber and mild hypothermic mattress, so that neonates can receive the treatment of hyperbaric oxygen chamber and/or mild hypothermic mattress based on their conditions. Meanwhile, it can realize the real-time monitoring of various physiological information, including amplitude-integrated electroencephalogram, electrocardiogram, and near-infrared spectrum, which can monitor brain function, heart rate, rhythm, myocardial blood supply, hemoglobin concentration in brain tissue, and blood oxygen saturation. In combination with an intelligent control algorithm, the device can intelligently regulate parameters according to the physiological information of neonates and give recommendations for subsequent treatment.


Asunto(s)
Recién Nacido , Humanos , Hipotermia Inducida/métodos , Hipotermia/terapia , Oxigenoterapia Hiperbárica , Encéfalo , Electroencefalografía , Hipoxia-Isquemia Encefálica/terapia
2.
Artículo en Chino | WPRIM | ID: wpr-689616

RESUMEN

<p><b>OBJECTIVE</b>To study the effect of rhubarb on neonatal rats with bronchopulmonary dysplasia (BPD) induced by hyperoxia.</p><p><b>METHODS</b>A total of 64 rats (postnatal day 4) were randomly divided into four groups: air control, rhubarb control, hyperoxia model, and hyperoxia+rhubarb (n=16 each). The rats in the hyperoxia model and hyperoxia+rhubarb groups were exposed to hyperoxia (60% O2) to establish a BPD model. The rats in the rhubarb control and hyperoxia+rhubarb groups were given rhubarb extract suspension (600 mg/kg) by gavage daily. The pathological changes of lung tissue were evaluated by hematoxylin-eosin staining on postnatal days 14 and 21. The content of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were measured by spectrophotometry. The mRNA and protein expression levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were determined by RT-PCR and Western blot respectively.</p><p><b>RESULTS</b>The hyperoxia model group showed reduced alveolar number, increased alveolar volume, and simplified alveolar structure, which worsened over the time of exposure to hyperoxia. These pathological changes were significantly reduced in the hyperoxia+rhubarb group. On postnatal days 14 and 21, compared with the air control and rhubarb control groups, the hyperoxia model group had significantly reduced radical alveolar count (RAC), significantly reduced activity of SOD in the lung tissue, and significantly increased content of MDA and mRNA and protein expression levels of TNF-α and IL-6 (P<0.05). Compared with the hyperoxia model group, the hyperoxia+rhubarb group had significantly increased RAC, significantly increased activity of SOD in the lung tissue, and significantly reduced content of MDA and mRNA and protein expression levels of TNF-α and IL-6 (P<0.05).</p><p><b>CONCLUSIONS</b>Rhubarb may play a protective role in rats with BPD induced by hyperoxia through inhibiting inflammatory response and oxidative stress.</p>


Asunto(s)
Animales , Ratas , Animales Recién Nacidos , Displasia Broncopulmonar , Metabolismo , Patología , Modelos Animales de Enfermedad , Hiperoxia , Pulmón , Metabolismo , Patología , Extractos Vegetales , Usos Terapéuticos , Ratas Sprague-Dawley , Rheum , Superóxido Dismutasa , Metabolismo , Factor de Necrosis Tumoral alfa , Genética
3.
Artículo en Chino | WPRIM | ID: wpr-334925

RESUMEN

<p><b>OBJECTIVE</b>To investigate therapeutic effect of high-dose intravenous immunoglobulin (IVIG) for early management of ABO hemolytic disease of the newborn (ABO-HDN).</p><p><b>METHODS</b>A total of 121 cases with ABO-HDN were randomly divided into treatment group (n=61) and control group (n=60). In addition to the routine treatment of the control group, IVIG were given at a daily dose of 400 mg/kg to the cases in the treatment group for 2-3 times, and therapeutic effects were evaluated and compared between the two groups.</p><p><b>RESULTS</b>The serum total billirubin concentration on the third day after treatment (153.42-/+45.21 micromol/L) and mean daily serum total billirubin concentration reduction (56.49-/+24.05 micromol/L) in treatment group were lower than those in the control group (P<0.01). The jaundice resolution time (23.51-/+11.19 h) and the phototherapy time (3.01-/+0.89 h) for billirubinemia treatment in treatment group were shorter than those in the control group (P<0.01). The patients in the the treatment group had higher hemoglobin level after treatment (15.59-/+2.01 g/L) than those of the control group (P<0.01).</p><p><b>CONCLUSION</b>High-dose IVIG can effectively arrest the progression of hemolytic disease, quickly reduce serum total billirubin concentration and shorten phototherapy time for early treatment of ABO-HDN.</p>


Asunto(s)
Femenino , Humanos , Recién Nacido , Masculino , Sistema del Grupo Sanguíneo ABO , Bilirrubina , Sangre , Eritroblastosis Fetal , Sangre , Quimioterapia , Alergia e Inmunología , Inmunoglobulinas Intravenosas , Usos Terapéuticos , Factores Inmunológicos , Usos Terapéuticos , Ictericia Neonatal , Quimioterapia , Factores de Tiempo , Resultado del Tratamiento
4.
Acta Pharmaceutica Sinica ; (12): 461-466, 2006.
Artículo en Chino | WPRIM | ID: wpr-271443

RESUMEN

<p><b>AIM</b>To prepare capsaicin transfersomes and evaluate them in vitro and in vivo.</p><p><b>METHODS</b>Capsaicin transfersomes were prepared by high shear dispersing machine and evaluated by entrapment efficiency, release rate, in vitro skin permeation and distribution in different tissues in vivo.</p><p><b>RESULTS</b>Capsaicin transfersomes were composed of single unilamellar vesicles with an average diameter of 150.6 nm. Capsaicin entrapment efficiency increased distinctly with increasing of concentration of lecithin and entrapment efficiency is 96.7% while concentration of lecithin to 8%. Cumulative release amount of capsaicin is in direct proportion to the ethanol concentration in the receptor medium. In vitro capsaicin cumulative penetration amount showed higher levels in transfersomes than cream and suspension in rat abdominal skin. Abdominal skin cumulative penetration amount in vitro of capsaicin transfersomes in mouse was significantly higher than that from rat and men. In the same way, abdominal skin epidermal membrane cumulative penetration amount in vitro of capsaicin transfersomes was significantly higher than that from derma and full skin in human abdominal skin. The capsaicin tissue distribution of capsaicin injection by multiple celiac injections in rats is different: bone > plasma > skin > muscle. There is a similar result by multiple thigh topical application of capsaicin transfersomes: bone > skin > plasma > muscle.</p><p><b>CONCLUSION</b>Entrapment efficiency of capsaicin transfersomes reached the criterion of China Pharmacopoeia (> 80%) and capsaicin skin penetration can be increased by capsaicin transfersomes. It should be noted that the diverse characters and levels of skin may probably affect the permeating capability of capsaicin. Capsaicin tissue distribution in bone and muscle is similar and is different in plasma and skin by multiple injections and topical skin apply.</p>


Asunto(s)
Animales , Humanos , Masculino , Ratones , Ratas , Administración Cutánea , Antiinflamatorios no Esteroideos , Farmacocinética , Capsaicina , Farmacocinética , Portadores de Fármacos , Sistemas de Liberación de Medicamentos , Lecitinas , Química , Tamaño de la Partícula , Ratas Sprague-Dawley , Absorción Cutánea , Colato de Sodio , Química , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA